Exane Derivatives’s Accenture ACN Stock Holding History

Exane Derivatives’s Portfolio ACN Stock Details ACN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$402K	Sell	1,447 -767	-35%	-$230K	0.23%	109
2022 Q1	$747K	Buy	2,214 +1,206	+120%	+$407K	0.21%	128
2021 Q4	$418K	Buy	1,008 +8	+0.8%	+$2.92K	0.1%	204
2021 Q3	$320K	Hold	1,000	–	–	0.08%	270
2021 Q2	$313K	Hold	1,000	–	–	0.07%	277
2021 Q1	$276K	Buy	+1,000	New	+$258K	0.08%	243
2019 Q3	–	Sell	-559	Closed	-$103K	–	654
2019 Q2	$103K	Sell	559 -927	-62%	-$166K	0.02%	328
2019 Q1	$261K	Sell	1,486 -121	-8%	-$19K	0.05%	199
2018 Q4	$227K	Buy	1,607 +400	+33%	+$63.3K	0.04%	233
2018 Q3	$206K	Buy	1,207 +751	+165%	+$125K	0.04%	239
2018 Q2	$75K	Sell	456 -448	-50%	-$69.7K	0.01%	360
2018 Q1	$134K	Sell	904 -10,501	-92%	-$1.66M	0.03%	269
2017 Q4	$1.75M	Buy	11,405 +11,062	+3,225%	+$1.6M	0.3%	54
2017 Q3	$46.3K	Buy	+343	New	+$44.7K	0.01%	312
2017 Q1	–	Sell	-949	Closed	-$111K	–	571
2016 Q4	$111K	Sell	949 -5	-0.5%	-$593	0.02%	241
2016 Q3	$117K	Hold	954	–	–	0.02%	234
2016 Q2	$108K	Buy	954 +457	+92%	+$53K	0.02%	239
2016 Q1	$57.3K	Buy	497 +245	+97%	+$25.2K	0.01%	292
2015 Q4	$26.3K	Buy	252 +251	+25,100%	+$26.5K	﹤0.01%	283
2015 Q3	$98	Buy	+1	New	+$99	﹤0.01%	494

Other funds holding ACN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Derivatives's ACN Position: Q2 2022 in Review

Exane Derivatives reduced its Accenture (ACN) stake by 35% in Q2 2022, selling an estimated $230K and leaving 1,447 shares worth $402K. The position accounts for 0.23% of the portfolio, ranked #109.

Exane Derivatives first reported a position in ACN in Q3 2015 and has held it in 20 quarters since. The position peaked at $1.75M in Q4 2017. 2,012 funds tracked by Wall St. Rank hold ACN as of Q2 2022.

Exane Derivatives held 1,447 shares of Accenture worth $402K as of Q2 2022.
Exane Derivatives sold 767 Accenture shares in Q2 2022, an estimated $230K.
Accenture made up 0.23% of Exane Derivatives's portfolio in Q2 2022, its #109 holding.
Exane Derivatives first reported a position in Accenture in Q3 2015 and has held it in 20 quarters since.
Exane Derivatives's Accenture position peaked at $1.75M in Q4 2017.
2,012 funds tracked by Wall St. Rank held Accenture as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.